FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Bio-techne Corp
TE

Bio-techne Corp

TECHNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 16 of 87 tracked investors

$72.60
▼ 0.12%
Famous investorshold 16buying 1selling 0
Price (USD)
$72.60
Market cap
$11.4B
P/E ratio
62.6
Tracked investors holding
16 of 87
Next earnings
4 Nov 2026

Bio-techne Corp at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
63out of 100
  • Valuation15
  • Growth41
  • Profitability80
  • Quality70
  • Debt90
  • Stability83
In its favour
  • It could repay its net debt from free cash flow in 0.1 years.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202612 Aug 20260.490.46+6.5%
Mar 20266 May 20260.480.480%
Dec 20254 Feb 20260.390.34+14.7%
Sep 20255 Nov 20250.360.360%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

Chart TECH

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

16
WW
Wallace Weitz
Weitz Investment Management
2.66%$38,377,080▼ -16.8%
LA
Lee Ainslie
Maverick Capital
0.96%$108,490,847▼ -67.6%
GS
George Soros
Soros Fund Management
0.46%$37,826,010New position
HE
Henry Ellenbogen
Durable Capital Partners
0.34%$35,463,686▼ -88.7%
LB
Louis Bacon
Moore Capital Management
0.13%$8,875,477New position
PT
Paul Tudor Jones
Tudor Investment Corp
0.09%$66,643,227New position
LR
Larry Robbins
Glenview Capital
0.08%$4,120,591▼ -68.7%
IE
Israel Englander
Millennium Management
0.03%$69,875,181New position
Čn
Česká národní banka
Česká národní banka
0.02%$3,260,135▲ +0.9%
RD
Ray Dalio
Bridgewater Associates
0.01%$1,889,888▲ +347.5%
JG
Joel Greenblatt
Gotham Asset Management
0.01%$5,028,514▲ +169.4%
KG
Ken Griffin
Citadel Advisors
0.01%$68,242,106▲ +2,125.5%
Ns
Norský státní fond
Norges Bank
0.01%$99,873,595New position
Šn
Švýcarská národní banka
Swiss National Bank
0.01%$22,184,100▲ +1.8%
MG
Mario Gabelli
GAMCO Investors
0%$441,563New position
RB
Ron Baron
Baron Capital
0%$127,170▼ -99.7%

Frequently asked questions

How much is Bio-techne Corp (TECH) stock?

Bio-techne Corp shares trade at $72.60, -0.12% over the last trading day. The price is delayed.

What is the market cap of Bio-techne Corp?

The market cap of Bio-techne Corp is about $11.4B and its price-to-earnings ratio (P/E) is 62.6.

Which big investors hold Bio-techne Corp?

According to the latest 13F filings, 16 of 87 tracked investors hold Bio-techne Corp, for example Wallace Weitz, Lee Ainslie, George Soros.

When will Bio-techne Corp report its next results?

The next earnings report of Bio-techne Corp is expected on 4 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
  • ✓It pays a 0.4% dividend, which takes 28% of earnings.
  • What to watch
    • !Revenue grew only 2.2% a year over 3 years.
    • !The stock is expensive: you pay 62.6 USD for 1 USD of annual earnings.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Expensive

    For 1 USD of annual earnings you pay 62.6 USD. Based on next year's estimates 31.4 USD.

    P/E
    62.6×
    P/S
    9.4×
    EV/EBITDA
    34.2×

    Is the company growing?

    Growing slowly
    23
    24
    25
    26

    Revenue over 3 years grew 2.2% a year. Last year 1.3%.

    Does it make money?

    Good
    • Cost of sales 34
    • Research 7.8
    • Operations and selling 35.5
    • Taxes and other 7.5
    • Net profit 15.0

    Out of 100 USD of revenue, 15.0 USD is left as net profit.

    Is it financially healthy?

    Yes
    Cash
    265M USD
    Debt
    289M USD
    Free CF
    230M USD

    It could repay its net debt from free cash flow in 0.1 years.

    Does it pay a dividend?

    Pays
    Yield
    0.44%
    Of earnings
    28%

    Over a year you receive roughly 0.44% of the price per share. The payout is manageable for the company.

    What do analysts expect?

    Hold
    Average target
    70.50 USD
    Vs price
    −3%

    10 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    16 of 87

    Among the tracked investors, Wallace Weitz, Lee Ainslie, George Soros and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    62.6×
    Forward P/E
    31.4×
    P/B
    5.4×
    P/S
    9.4×
    PEG
    2.12
    EV/EBITDA
    34.2×
    Gross margin
    66.2%
    Operating margin
    27.9%
    Net margin
    15.0%
    ROE
    9.0%
    ROA
    6.7%
    Debt / equity
    0.1×
    Current ratio
    4.5×
    Revenue growth
    1.3%
    Earnings growth
    –
    Beta
    1.30
    Dividend
    0.44%
    Payout ratio
    28%